$OPNT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in OPIANT PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in OPIANT PHARMACEUTICALS, INC.. Get notifications about new insider transactions in OPIANT PHARMACEUTICALS, INC. for free.

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 13 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	341	3,410	0
May 13 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	341	3,410	21,179	20.8 K to 21.2 K (+1.64 %)
Mar 22 2021	OPNT	OPIANT PHARMACEUTI ...	Lorianne Masuoka K.	Director	Option Exercise	A	10.80	5,000	54,000	5,000
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	7,279	72,790	341
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	2,231	22,310	7,620
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	6,483	64,830	9,851
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.07	6,606	73,128	20,838	27.4 K to 20.8 K (-24.07 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	7,279	72,790	27,444	20.2 K to 27.4 K (+36.10 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.50	1,949	22,414	20,165	22.1 K to 20.2 K (-8.81 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	2,231	22,310	22,114	19.9 K to 22.1 K (+11.22 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.63	5,600	65,128	19,883	25.5 K to 19.9 K (-21.98 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	6,483	64,830	25,483	19 K to 25.5 K (+34.12 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	7,279	72,790	341
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	2,231	22,310	7,620
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	6,483	64,830	9,851
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.07	6,606	73,128	20,838	27.4 K to 20.8 K (-24.07 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	7,279	72,790	27,444	20.2 K to 27.4 K (+36.10 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.50	1,949	22,414	20,165	22.1 K to 20.2 K (-8.81 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	2,231	22,310	22,114	19.9 K to 22.1 K (+11.22 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	7,886	78,860	365
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Sell	S	11.63	5,600	65,128	19,883	25.5 K to 19.9 K (-21.98 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	2,231	22,310	8,251
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	6,483	64,830	25,483	19 K to 25.5 K (+34.12 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	4,518	45,180	10,482
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.07	7,157	79,228	16,478	23.6 K to 16.5 K (-30.28 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	7,886	78,860	23,635	15.7 K to 23.6 K (+50.07 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.50	1,949	22,414	15,749	17.7 K to 15.7 K (-11.01 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	2,231	22,310	17,698	15.5 K to 17.7 K (+14.42 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.64	3,900	45,396	15,467	19.4 K to 15.5 K (-20.14 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	4,518	45,180	19,367	14.8 K to 19.4 K (+30.43 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	7,886	78,860	365
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	2,231	22,310	8,251
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	4,518	45,180	10,482
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.07	7,157	79,228	16,478	23.6 K to 16.5 K (-30.28 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	7,886	78,860	23,635	15.7 K to 23.6 K (+50.07 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.50	1,949	22,414	15,749	17.7 K to 15.7 K (-11.01 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	2,231	22,310	17,698	15.5 K to 17.7 K (+14.42 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Sell	S	11.64	3,900	45,396	15,467	19.4 K to 15.5 K (-20.14 %)
Mar 17 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	4,518	45,180	19,367	14.8 K to 19.4 K (+30.43 %)
Mar 08 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	M	10.00	8,334	83,340	15,000
Mar 08 2021	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	M	10.00	8,334	83,340	14,849	6.5 K to 14.8 K (+127.92 %)
Feb 16 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	M	10.00	7,000	70,000	16,334
Feb 16 2021	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	M	10.00	7,000	70,000	19,000	12 K to 19 K (+58.33 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Option Exercise	A	12.15	31,250	379,688	31,250
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Grant	A	0.00	15,650	0	41,541	25.9 K to 41.5 K (+60.45 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Grant	A	0.00	3,766	0	25,891	22.1 K to 25.9 K (+17.02 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	12.15	10,750	130,613	10,750
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	5,400	0	23,215	17.8 K to 23.2 K (+30.31 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	2,450	0	17,815	15.4 K to 17.8 K (+15.95 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath	Chief Development O ...	Option Exercise	A	12.15	10,750	130,613	10,750
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath	Chief Development O ...	Grant	A	0.00	5,400	0	7,636	2.2 K to 7.6 K (+241.50 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath	Chief Development O ...	Grant	A	0.00	2,236	0	2,236	0 to 2.2 K
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	A	12.15	10,750	130,613	10,750
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Grant	A	0.00	5,400	0	12,348	6.9 K to 12.3 K (+77.72 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Grant	A	0.00	2,798	0	6,948	4.2 K to 6.9 K (+67.42 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Gorman Brian		Option Exercise	A	12.15	10,750	130,613	10,750
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Gorman Brian		Grant	A	0.00	5,400	0	20,274	14.9 K to 20.3 K (+36.30 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	Gorman Brian		Grant	A	0.00	1,374	0	14,874	13.5 K to 14.9 K (+10.18 %)
Sep 08 2020	OPNT	OPIANT PHARMACEUTI ...	Thomas Thomas T.	Director	Buy	P	8.05	500	4,025	5,000	4.5 K to 5 K (+11.11 %)
Sep 08 2020	OPNT	OPIANT PHARMACEUTI ...	Thomas Thomas T.	Director	Buy	P	8.40	2,500	21,000	4,500	2 K to 4.5 K (+125.00 %)
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Sinclair Michael	Director	Grant	A	0.00	2,000	0	71,220	69.2 K to 71.2 K (+2.89 %)
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Daly Richard J	Director	Option Exercise	A	8.79	2,500	21,975	2,500
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Daly Richard J	Director	Grant	A	0.00	2,000	0	3,800	1.8 K to 3.8 K (+111.11 %)
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	A	8.79	2,500	21,975	2,500
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Grant	A	0.00	2,000	0	6,515	4.5 K to 6.5 K (+44.30 %)
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Thomas Thomas T.	Director	Option Exercise	A	8.79	2,500	21,975	2,500
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Thomas Thomas T.	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	A	8.79	2,500	21,975	2,500
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Grant	A	0.00	2,000	0	12,000	10 K to 12 K (+20.00 %)
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Collard Craig A	Director	Option Exercise	A	8.79	2,500	21,975	2,500
Jun 15 2020	OPNT	OPIANT PHARMACEUTI ...	Collard Craig A	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Jun 12 2020	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	P	9.13	2,730	24,925	4,515	1.8 K to 4.5 K (+152.94 %)
Jun 11 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	8.74	1,000	8,740	15,365	14.4 K to 15.4 K (+6.96 %)
May 26 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	11.00	1,000	11,000	14,365	13.4 K to 14.4 K (+7.48 %)
Mar 02 2020	OPNT	OPIANT PHARMACEUTI ...	Daly Richard J	Director	Buy	P	13.90	1,800	25,020	1,800	0 to 1.8 K
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	13.60	8,250	112,200	8,250
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	4,150	0	13,365	9.2 K to 13.4 K (+45.04 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	A	13.60	8,250	112,200	8,250
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.36	3,043	40,654	4,150	7.2 K to 4.2 K (-42.31 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.46	2,842	38,253	7,193	10 K to 7.2 K (-28.32 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Grant	A	0.00	4,150	0	10,035	5.9 K to 10 K (+70.52 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.60	2,900	39,440	5,885	8.8 K to 5.9 K (-33.01 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath		Option Exercise	A	13.60	8,250	112,200	8,250
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath		Grant	A	0.00	4,150	0	9,680	5.5 K to 9.7 K (+75.05 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Option Exercise	A	13.60	27,250	370,600	27,250
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Grant	A	0.00	13,650	0	22,125	8.5 K to 22.1 K (+161.06 %)
Jan 06 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	40,000
Jan 06 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.80	515	7,107	8,785	9.3 K to 8.8 K (-5.54 %)
Jan 06 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.08	700	9,856	9,300	10 K to 9.3 K (-7.00 %)
Jan 06 2020	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Dec 12 2019	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Buy	P	14.54	5,000	72,700	10,000	5 K to 10 K (+100.00 %)
Dec 06 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.34	800	10,672	0	800 to 0 (-100.00 %)
Dec 06 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.74	2,057	28,263	800	2.9 K to 800 (-72.00 %)
Dec 06 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.34	800	10,672	0	800 to 0 (-100.00 %)
Dec 06 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.74	2,057	28,263	800	2.9 K to 800 (-72.00 %)
Dec 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	50,000
Dec 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.93	4,578	63,772	2,857	7.4 K to 2.9 K (-61.57 %)
Dec 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.17	2,565	36,346	7,435	10 K to 7.4 K (-25.65 %)
Dec 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Nov 26 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	13.22	100	1,322	9,215	9.1 K to 9.2 K (+1.10 %)
Nov 25 2019	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Buy	P	13.51	1,785	24,115	1,785	0 to 1.8 K
Nov 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.00	100	1,500	9,115	9 K to 9.1 K (+1.11 %)
Nov 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	14.91	1,000	14,910	9,015	8 K to 9 K (+12.48 %)
Nov 05 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	60,000
Nov 05 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.89	2,500	37,225	0	2.5 K to 0 (-100.00 %)
Nov 05 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	15.28	299	4,569	2,500	2.8 K to 2.5 K (-10.68 %)
Nov 05 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	15.10	7,201	108,735	2,799	10 K to 2.8 K (-72.01 %)
Nov 05 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Oct 03 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	70,000
Oct 03 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.27	1,609	22,960	0	1.6 K to 0 (-100.00 %)
Oct 03 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.57	1,102	16,056	1,609	2.7 K to 1.6 K (-40.65 %)
Oct 03 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.79	7,289	107,804	2,711	10 K to 2.7 K (-72.89 %)
Oct 03 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Sep 13 2019	OPNT	OPIANT PHARMACEUTI ...	Sinclair Michael	Director	Sell	S	12.52	60,000	751,200	69,220	129.2 K to 69.2 K (-46.43 %)
Sep 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	80,000
Sep 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.37	2,494	35,839	0	2.5 K to 0 (-100.00 %)
Sep 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	14.08	7,506	105,684	2,494	10 K to 2.5 K (-75.06 %)
Sep 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Aug 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.20	1,000	15,200	8,015	7 K to 8 K (+14.26 %)
Aug 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.20	1,000	15,200	8,015	7 K to 8 K (+14.26 %)
Aug 13 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.46	1,000	15,460	7,015	6 K to 7 K (+16.63 %)
Aug 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	90,000
Aug 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	11.30	1,558	17,605	0	1.6 K to 0 (-100.00 %)
Aug 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	11.66	8,442	98,434	1,558	10 K to 1.6 K (-84.42 %)
Aug 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Jul 30 2019	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath		Option Exercise	M	10.00	30,000	300,000	0
Jul 30 2019	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath		Payment of Exercise	F	12.26	24,470	300,002	5,530	30 K to 5.5 K (-81.57 %)
Jul 30 2019	OPNT	OPIANT PHARMACEUTI ...	Ellison Mark Jason Heath		Buy	M	10.00	30,000	300,000	30,000	0 to 30 K
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	100,000
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	100,000
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.16	2,195	28,886	0	2.2 K to 0 (-100.00 %)
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.16	2,195	28,886	0	2.2 K to 0 (-100.00 %)
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.20	7,805	103,026	2,195	10 K to 2.2 K (-78.05 %)
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	13.20	7,805	103,026	2,195	10 K to 2.2 K (-78.05 %)
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Jul 02 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Jun 13 2019	OPNT	OPIANT PHARMACEUTI ...	Thomas Thomas T.	Director	Option Exercise	A	12.75	2,500	31,875	2,500
Jun 13 2019	OPNT	OPIANT PHARMACEUTI ...	Daly Richard J	Director	Option Exercise	A	12.75	2,500	31,875	2,500
Jun 13 2019	OPNT	OPIANT PHARMACEUTI ...	MacDougall Ann L.	Director	Option Exercise	A	12.75	2,500	31,875	2,500
Jun 13 2019	OPNT	OPIANT PHARMACEUTI ...	Silver Gabrielle Alison	Director	Option Exercise	A	12.75	2,500	31,875	2,500
Jun 13 2019	OPNT	OPIANT PHARMACEUTI ...	Collard Craig A	Director	Option Exercise	A	12.75	2,500	31,875	2,500
Jun 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Option Exercise	M	9.00	10,000	90,000	110,000
Jun 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	11.63	1,586	18,445	0	1.6 K to 0 (-100.00 %)
Jun 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Sell	S	11.72	8,414	98,612	1,586	10 K to 1.6 K (-84.14 %)
Jun 04 2019	OPNT	OPIANT PHARMACEUTI ...	Skolnick Phil	Chief Scientific Of ...	Buy	M	9.00	10,000	90,000	10,000	0 to 10 K
Apr 08 2019	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Option Exercise	M	7.25	21,472	155,672	375,000
Apr 08 2019	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Sell	S	12.10	12,772	154,541	8,475	21.2 K to 8.5 K (-60.11 %)
Apr 08 2019	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Sell	S	11.98	16,001	191,692	21,247	37.2 K to 21.2 K (-42.96 %)
Apr 08 2019	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Buy	M	7.25	21,472	155,672	37,248	15.8 K to 37.2 K (+136.11 %)
Apr 04 2019	OPNT	OPIANT PHARMACEUTI ...	CRYSTAL ROGER	Chief Executive Off ...	Option Exercise	M	7.25	22,557	163,538	396,472

Page: 1 2 3 next >